US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amylyx Pharmaceuticals

7.72

-0.3150-3.92%

Post-market: 7.42-0.2950-3.82%18:49 EDT

Volume:1.84M

Turnover:14.53M

Market Cap:687.72M

PE:-2.56

High:8.08

Open:7.87

Low:7.69

Close:8.03

Loading ...

Overview Company News Filings

H.C. Wainwright Remains a Buy on Amylyx Pharmaceuticals Inc (AMLX)

Amylyx presents new analyses from Phase 2, Phase 2b trials of avexitide

Amylyx Pharmaceuticals Announces Promising Phase 2b Trial Results for Avexitide in Treating Post-Bariatric Hypoglycemia

Amylyx Pharmaceuticals Price Target Announced at $10.00/Share by Goldman Sachs

Amylyx resumed with a Buy at Goldman Sachs

Promising Potential of Avexitide Drives Amylyx Pharmaceuticals’ Growth Prospects

Amylyx Pharmaceuticals Announces New Insights from Avexitide Clinical Trials for Post-Bariatric Hypoglycemia at ENDO 2025

Guggenheim Initiates Amylyx Pharmaceuticals at Buy With $17 Price Target

MT Newswires Live

Amylyx initiated with a Buy at Guggenheim

Amylyx Pharmaceuticals Initiated at Buy by Citigroup

Amylyx initiated with a Buy at Citi

Amylyx Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Amylyx Pharmaceuticals Announces FDA Fast Track Designation for AMX0114 in ALS Treatment, Phase 1 LUMINA Trial Underway

Amylyx Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

Amylyx Pharmaceuticals Is Maintained at Outperform by Mizuho

Mizuho Adjusts Price Target on Amylyx Pharmaceuticals to $8 From $7, Maintains Outperform Rating

MT Newswires Live

Amylyx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Amylyx price target raised to $16 from $12 at H.C. Wainwright

Amylyx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Amylyx Pharma Q1 EPS $(0.42) Beats $(0.49) Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AMLX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMLX\",,,,,undefined,":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals","latestPrice":7.715,"timestamp":1754078400000,"preClose":8.03,"halted":0,"volume":1838731,"hourTrading":{"tag":"盘后","latestPrice":7.42,"preClose":7.715,"latestTime":"18:49 EDT","volume":26891,"amount":207119.44,"timestamp":1754088577008},"delay":0,"floatShares":50976320,"shares":89141087,"eps":-3.016186,"marketStatus":"Market Closed","change":-0.315,"latestTime":"08-01 16:00:00 EDT","open":7.87,"high":8.08,"low":7.685,"amount":14527311.657437,"amplitude":0.049191,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.016186,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1641531600000,"exchange":"NASDAQ","adjPreClose":8.03,"dividendRate":0.00013,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":7.86,"preClose":8.03,"latestTime":"09:29 EDT","volume":1159,"amount":9257.769798,"timestamp":1754054999999},"postHourTrading":{"tag":"盘后","latestPrice":7.42,"preClose":7.715,"latestTime":"18:49 EDT","volume":26891,"amount":207119.44,"timestamp":1754088577008},"volumeRatio":1.915676871624304,"impliedVol":0.489,"impliedVolPercentile":0.252},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMLX\",,,,,undefined,":{"symbol":"AMLX","floatShares":50976320,"roa":"-40.72%","roe":"-83.24%","lyrEps":-4.428139,"volumeRatio":1.915676871624304,"shares":89141087,"dividePrice":0.001,"high":8.08,"amplitude":0.049191,"preClose":8.03,"low":7.685,"week52Low":1.76,"pbRate":"3.41","psRate":"-540.66","week52High":8.72,"institutionHeld":0,"latestPrice":7.715,"eps":-3.016186,"divideRate":0.00013,"volume":1838731,"delay":0,"ttmEps":-3.016186,"open":7.87,"prevYearClose":3.78,"prevWeekClose":8.15,"prevMonthClose":8.03,"prevQuarterClose":6.41,"fiveDayClose":8.15,"twentyDayClose":6.3,"sixtyDayClose":4.65,"earningDate":1754496000000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AMLX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2551208189","title":"H.C. Wainwright Remains a Buy on Amylyx Pharmaceuticals Inc (AMLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2551208189","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551208189?lang=en_us&edition=fundamental","pubTime":"2025-07-14 20:45","pubTimestamp":1752497109,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Amylyx Pharmaceuticals Inc today and set a price target of $16.00. The company’s sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-amylyx-pharmaceuticals-inc-amlx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-amylyx-pharmaceuticals-inc-amlx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2551489929","title":"Amylyx presents new analyses from Phase 2, Phase 2b trials of avexitide","url":"https://stock-news.laohu8.com/highlight/detail?id=2551489929","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551489929?lang=en_us&edition=fundamental","pubTime":"2025-07-14 08:15","pubTimestamp":1752452114,"startTime":"0","endTime":"0","summary":"Amylyx (AMLX) Pharmaceuticals announced the presentation of new exploratory analyses from the Phase 2 PREVENT and Phase 2b clinical trials of avexi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-presents-new-analyses-from-phase-2-phase-2b-trials-of-avexitide-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-presents-new-analyses-from-phase-2-phase-2b-trials-of-avexitide-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2551233759","title":"Amylyx Pharmaceuticals Announces Promising Phase 2b Trial Results for Avexitide in Treating Post-Bariatric Hypoglycemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2551233759","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551233759?lang=en_us&edition=fundamental","pubTime":"2025-07-14 05:00","pubTimestamp":1752440418,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc. has announced new exploratory analyses from their Phase 2 PREVENT and Phase 2b clinical trials of avexitide, an investigational GLP-1 receptor antagonist for treating post-bariatric hypoglycemia . The results, presented at the Endocrine Society's annual meeting , demonstrated that avexitide 90 mg once daily led to a 64% reduction in the composite rate of Level 2 and Level 3 hypoglycemic events. This outcome aligns with the primary goal of the ongoing Phase 3 LUCIDITY trial, which is expected to complete recruitment in 2025, with topline data anticipated in the first half of 2026. The pharmacokinetic and pharmacodynamic data indicate sustained therapeutic exposure for 24 hours with the avexitide 90 mg once daily dose. Camille L. Bedrosian, MD, Chief Medical Officer of Amylyx, noted that the trials showed significant reductions in hypoglycemic events, suggesting potential benefits for those with PBH. The investor event to discuss these findings will be held vi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250713:nNDL4yMd7C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2550781426","title":"Amylyx Pharmaceuticals Price Target Announced at $10.00/Share by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2550781426","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550781426?lang=en_us&edition=fundamental","pubTime":"2025-07-11 02:22","pubTimestamp":1752171720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 10, 2025 14:22 ET (18:22 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2550264836","title":"Amylyx resumed with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2550264836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550264836?lang=en_us&edition=fundamental","pubTime":"2025-07-10 17:05","pubTimestamp":1752138323,"startTime":"0","endTime":"0","summary":"Goldman Sachs resumed coverage of Amylyx (AMLX) with a Buy rating and $10 price target suggesting 58% upside. The firm has a positive view on avexi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-resumed-with-a-buy-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-resumed-with-a-buy-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0742534661.SGD","BK4550","LU0096364046.USD","LU1894683264.USD","LU2237443978.SGD","LU2237438978.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4588","LU1668664300.SGD","AMLX","BK4552","LU2237443382.USD","LU2750360641.GBP","LU2471134952.CNY","BK4127","LU2471134796.USD","BK4504","LU1791807156.HKD","IE00BFXG1179.USD","BK4585","IE0034235188.USD","LU0106831901.USD","IE0002270589.USD","LU0251142724.SGD","LU2471134523.USD","IE0004091025.USD","LU1894683348.USD","LU1868836591.USD","LU0048573561.USD","BK4516","LU1868836914.USD","LU2471134879.HKD","BK4007","IE00BSNM7G36.USD","LU0061475181.USD","IE0004086264.USD","LU1868837300.USD","BK4533","LU2237443465.HKD","LU2237443549.SGD","LU0251131958.USD","LU2750360997.AUD","LU2237443622.USD","LU1868837136.USD","LU2237443895.HKD","LU1868836757.USD"],"gpt_icon":0},{"id":"2550861604","title":"Promising Potential of Avexitide Drives Amylyx Pharmaceuticals’ Growth Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=2550861604","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550861604?lang=en_us&edition=fundamental","pubTime":"2025-07-10 15:25","pubTimestamp":1752132348,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc (AMLX) has received a new Buy rating, initiated by Goldman Sachs analyst, Corinne Johnson. Corinne Johnson’s rating is b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-potential-of-avexitide-drives-amylyx-pharmaceuticals-growth-prospects-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-potential-of-avexitide-drives-amylyx-pharmaceuticals-growth-prospects-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2471134879.HKD","LU0096364046.USD","BK4588","IE0034235188.USD","IE0002270589.USD","LU2471134523.USD","IE00B19Z3B42.SGD","LU0048573561.USD","LU2471134952.CNY","LU1868836757.USD","BK4127","LU1894683264.USD","LU2237443978.SGD","LU0251142724.SGD","AMLX","LU1868837136.USD","LU0742534661.SGD","IE00BFXG1179.USD","LU1868836591.USD","IE00B19Z3581.USD","IE0004086264.USD","LU0251131958.USD","LU2237438978.USD","BK4516","LU1894683348.USD","BK4007","LU0106831901.USD","LU1668664300.SGD","LU1868836914.USD","LU2750360997.AUD","IE00BSNM7G36.USD","BK4552","LU1791807156.HKD","LU2237443465.HKD","LU2237443622.USD","BK4533","LU2237443382.USD","LU0061475181.USD","LU2471134796.USD","LU2750360641.GBP","LU2237443549.SGD","IE0004091025.USD","LU2237443895.HKD","BK4550","BK4585","LU1868837300.USD","BK4504"],"gpt_icon":0},{"id":"2549493495","title":"Amylyx Pharmaceuticals Announces New Insights from Avexitide Clinical Trials for Post-Bariatric Hypoglycemia at ENDO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2549493495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549493495?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:00","pubTimestamp":1751972424,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc. has announced plans to host an investor event at the Endocrine Society's annual meeting  to discuss post-bariatric hypoglycemia  and avexitide, a potential first-in-class GLP-1 receptor antagonist. The event will take place on July 13, 2025, both in-person in San Francisco and virtually. The presentation will cover the current burden of PBH and provide background information on avexitide, which has received FDA breakthrough therapy designation. Additionally, the event will feature new exploratory analyses from the Phase 2 PREVENT and Phase 2b clinical trials of avexitide in PBH, with data focusing on composite rates of Level 2 and 3 hypoglycemic events, as well as pharmacokinetic and pharmacodynamic data demonstrating the continuous pharmacologic activity of the 90 mg once daily dose for 24 hours. The results of these studies will be presented during ENDO 2025. A live webcast of the presentation and Q&A will be available on Amylyx's website, with a replay ac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDL9kXV0n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2545289997","title":"Guggenheim Initiates Amylyx Pharmaceuticals at Buy With $17 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2545289997","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545289997?lang=en_us&edition=fundamental","pubTime":"2025-06-24 19:02","pubTimestamp":1750762975,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals (AMLX) has an average rating of buy and mean price target of $11, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMLX"],"gpt_icon":0},{"id":"2545928517","title":"Amylyx initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2545928517","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545928517?lang=en_us&edition=fundamental","pubTime":"2025-06-24 18:15","pubTimestamp":1750760134,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Seamus Fernandez initiated coverage of Amylyx (AMLX) with a Buy rating and $17 price target Published first on TheFly – the ulti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-initiated-with-a-buy-at-guggenheim-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-initiated-with-a-buy-at-guggenheim-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2544964177","title":"Amylyx Pharmaceuticals Initiated at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2544964177","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544964177?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:47","pubTimestamp":1750160820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 17, 2025 07:47 ET (11:47 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2544689219","title":"Amylyx initiated with a Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2544689219","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544689219?lang=en_us&edition=fundamental","pubTime":"2025-06-17 17:25","pubTimestamp":1750152315,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham initiated coverage of Amylyx (AMLX) with a Buy rating and $12 price target “There is a lot to like” within the company’s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-initiated-with-a-buy-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-initiated-with-a-buy-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2541072003","title":"Amylyx Pharmaceuticals Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2541072003","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541072003?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:04","pubTimestamp":1749153889,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc. held its Annual Meeting of Stockholders on June 5, 2025. During the meeting, stockholders voted on several proposals. Karen Firestone, Justin Klee, and Bernhardt Zeiher, M.D. were elected as Class I directors. The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Additionally, the compensation of the company's named executive officers was approved on a non-binding, advisory basis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amylyx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL7P9l1H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2540759907","title":"Amylyx Pharmaceuticals Announces FDA Fast Track Designation for AMX0114 in ALS Treatment, Phase 1 LUMINA Trial Underway","url":"https://stock-news.laohu8.com/highlight/detail?id=2540759907","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540759907?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:00","pubTimestamp":1748948423,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc. has announced the initiation of the LUMINA clinical trial, a Phase 1, multinational, randomized, double-blind, placebo-controlled study aimed at evaluating the safety and biological activity of its investigational drug, AMX0114, in individuals with amyotrophic lateral sclerosis . The trial will involve approximately 48 participants who will be randomized in a 3:1 ratio to receive either AMX0114 or placebo through intrathecal administration every four weeks, for a total of up to four doses. The study will also assess changes in ALS biomarkers, such as neurofilament light  levels. In conjunction with the trial, the U.S. Food and Drug Administration  has granted Fast Track designation to AMX0114, which targets calpain-2, a contributor to axonal degeneration in ALS. Early data from the trial's cohorts are anticipated in 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide acc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL9FrjR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2537982541","title":"Amylyx Pharmaceuticals to Participate in Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2537982541","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537982541?lang=en_us&edition=fundamental","pubTime":"2025-05-21 19:00","pubTimestamp":1747825217,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc. announced its participation in the Jefferies Global Healthcare Conference with a fireside chat scheduled for Thursday, June 5, 2025, at 1:25 p.m. ET in New York City.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amylyx Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on May 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL9brll4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2535079873","title":"Amylyx Pharmaceuticals Is Maintained at Outperform by Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2535079873","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535079873?lang=en_us&edition=fundamental","pubTime":"2025-05-14 22:54","pubTimestamp":1747234440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2025 10:54 ET (14:54 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MFG","AMLX"],"gpt_icon":0},{"id":"2535202157","title":"Mizuho Adjusts Price Target on Amylyx Pharmaceuticals to $8 From $7, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2535202157","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535202157?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:42","pubTimestamp":1747226577,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals (AMLX) has an average rating of overweight and mean price target of $10.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MFG","AMLX"],"gpt_icon":0},{"id":"2534006489","title":"Amylyx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2534006489","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534006489?lang=en_us&edition=fundamental","pubTime":"2025-05-09 20:44","pubTimestamp":1746794640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 09, 2025 08:44 ET (12:44 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2534152100","title":"Amylyx price target raised to $16 from $12 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2534152100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534152100?lang=en_us&edition=fundamental","pubTime":"2025-05-09 19:20","pubTimestamp":1746789652,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Amylyx (AMLX) to $16 from $12 and keeps a Buy rating on the shares after the company announced th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-price-target-raised-to-16-from-12-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-price-target-raised-to-16-from-12-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2533135585","title":"Amylyx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2533135585","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533135585?lang=en_us&edition=fundamental","pubTime":"2025-05-08 21:32","pubTimestamp":1746711166,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings SummaryAmylyx Pharmaceuticals Inc AMLX.OQ reported a quarterly adjusted loss of 42 cents per share for the quarter ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL8N3RG211:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2533838141","title":"Amylyx Pharma Q1 EPS $(0.42) Beats $(0.49) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533838141","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533838141?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:02","pubTimestamp":1746702142,"startTime":"0","endTime":"0","summary":"Amylyx Pharma (NASDAQ:AMLX) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.49) by 14.29 percent. This is a 76 percent increase over losses of $(1.75) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45281037/amylyx-pharma-q1-eps-0-42-beats-0-49-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMLX\",params:#limit:5,,,undefined,":[{"date":"2025-08-07","symbol":"AMLX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":-0.44,"defaultRemindTime":1754553600000,"name":null,"time":"Pre-Market","dateTimestamp":1754539200000,"actualEps":null},{"market":"US","date":"2025-05-08","symbol":"AMLX","fiscalQuarterEnding":"2025/03","expectedEps":-0.45,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2025-03-04","symbol":"AMLX","fiscalQuarterEnding":"2024/12","expectedEps":-0.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2024-11-07","symbol":"AMLX","fiscalQuarterEnding":"2024/09","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-08-08","symbol":"AMLX","fiscalQuarterEnding":"2024/06","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.73}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.4,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":10,"updateTime":1752206400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AMLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AMLX","date":"2025-08-01","current":-3.270642,"percent":0.538462,"low":-27.24786,"twenty":-13.033049,"median":-6.057475,"eighty":-0.94462,"high":660.566108,"avg":36.147031,"sd":148.867479,"marketCap":715802928},"quantilePoints":[{"date":"2022-01-07","current":-14.965618,"twenty":-15.735846,"median":-15.735846,"eighty":-15.273709,"marketCap":1020340854},{"date":"2022-01-14","current":-17.069252,"twenty":-16.953304,"median":-16.183076,"eighty":-15.273709,"marketCap":1163764527},{"date":"2022-01-21","current":-15.338309,"twenty":-17.016247,"median":-16.328011,"eighty":-15.417816,"marketCap":1045750560},{"date":"2022-01-28","current":-16.564048,"twenty":-16.799258,"median":-16.025717,"eighty":-15.619898,"marketCap":1129320260},{"date":"2022-02-04","current":-18.651119,"twenty":-18.372842,"median":-16.597176,"eighty":-15.696092,"marketCap":1271614612},{"date":"2022-02-11","current":-15.942897,"twenty":-17.579425,"median":-16.564048,"eighty":-15.735846,"marketCap":1086970750},{"date":"2022-02-18","current":-21.939082,"twenty":-18.462288,"median":-16.667574,"eighty":-15.754066,"marketCap":1495784684},{"date":"2022-02-25","current":-25.657711,"twenty":-19.073502,"median":-16.791804,"eighty":-15.826948,"marketCap":1749317082},{"date":"2022-03-04","current":-22.684464,"twenty":-21.939082,"median":-17.052688,"eighty":-15.942897,"marketCap":1546604096},{"date":"2022-03-11","current":-21.541545,"twenty":-22.684464,"median":-17.512341,"eighty":-16.025717,"marketCap":1468680998},{"date":"2022-03-18","current":-18.841605,"twenty":-22.361465,"median":-18.560016,"eighty":-16.24105,"marketCap":1284601795},{"date":"2022-03-25","current":-20.705061,"twenty":-21.939082,"median":-18.237018,"eighty":-16.28246,"marketCap":1411650325},{"date":"2022-04-01","current":-8.475859,"twenty":-21.905954,"median":-17.624148,"eighty":-15.826948,"marketCap":745290715},{"date":"2022-04-08","current":-8.982567,"twenty":-21.541545,"median":-17.06097,"eighty":-15.603334,"marketCap":789846138},{"date":"2022-04-14","current":-7.771731,"twenty":-21.528294,"median":-16.965727,"eighty":-13.72994,"marketCap":683376036},{"date":"2022-04-22","current":-6.560894,"twenty":-20.869045,"median":-16.804227,"eighty":-9.310283,"marketCap":576905934},{"date":"2022-04-29","current":-5.922572,"twenty":-20.605676,"median":-16.667574,"eighty":-8.660117,"marketCap":520777674},{"date":"2022-05-06","current":-5.034186,"twenty":-19.593613,"median":-16.564048,"eighty":-7.877021,"marketCap":442661022},{"date":"2022-05-13","current":-4.079021,"twenty":-19.267301,"median":-16.261755,"eighty":-7.076815,"marketCap":494605759},{"date":"2022-05-20","current":-4.199702,"twenty":-19.20767,"median":-15.942897,"eighty":-6.639861,"marketCap":509239066},{"date":"2022-05-27","current":-4.23832,"twenty":-19.098348,"median":-15.735846,"eighty":-6.288455,"marketCap":513921724},{"date":"2022-06-03","current":-5.961646,"twenty":-19.02381,"median":-15.644744,"eighty":-5.98953,"marketCap":722885341},{"date":"2022-06-10","current":-6.531261,"twenty":-18.965835,"median":-14.965618,"eighty":-5.946016,"marketCap":791954547},{"date":"2022-06-17","current":-8.606975,"twenty":-18.884671,"median":-12.812292,"eighty":-5.98953,"marketCap":1043647419},{"date":"2022-06-24","current":-9.031773,"twenty":-18.838292,"median":-9.572716,"eighty":-6.047604,"marketCap":1095156658},{"date":"2022-07-01","current":-9.398643,"twenty":-18.760441,"median":-9.500016,"eighty":-6.16474,"marketCap":1139641910},{"date":"2022-07-08","current":-10.721308,"twenty":-18.632898,"median":-9.557942,"eighty":-6.256367,"marketCap":1300022949},{"date":"2022-07-15","current":-9.89585,"twenty":-18.528544,"median":-9.681037,"eighty":-6.279867,"marketCap":1199931133},{"date":"2022-07-22","current":-10.644072,"twenty":-18.336402,"median":-9.891022,"eighty":-6.326623,"marketCap":1290657633},{"date":"2022-07-29","current":-13.028731,"twenty":-18.053157,"median":-10.004462,"eighty":-6.460206,"marketCap":1579811769},{"date":"2022-08-05","current":-12.029491,"twenty":-17.90905,"median":-10.243411,"eighty":-6.531923,"marketCap":1458647991},{"date":"2022-08-12","current":-9.562145,"twenty":-17.579425,"median":-10.400296,"eighty":-6.536805,"marketCap":1466842643},{"date":"2022-08-19","current":-9.485831,"twenty":-17.334277,"median":-10.06963,"eighty":-6.548772,"marketCap":1455135998},{"date":"2022-08-26","current":-10.039108,"twenty":-17.065939,"median":-9.989202,"eighty":-6.580636,"marketCap":1540009176},{"date":"2022-09-02","current":-6.898786,"twenty":-17.03778,"median":-9.89585,"eighty":-6.660919,"marketCap":1058280726},{"date":"2022-09-09","current":-11.401313,"twenty":-16.97815,"median":-9.89585,"eighty":-6.659603,"marketCap":1748972792},{"date":"2022-09-16","current":-11.210528,"twenty":-16.953304,"median":-9.989202,"eighty":-6.666184,"marketCap":1719706179},{"date":"2022-09-23","current":-10.634357,"twenty":-16.878765,"median":-10.096343,"eighty":-6.830104,"marketCap":1631321008},{"date":"2022-09-30","current":-10.741197,"twenty":-16.804227,"median":-10.278624,"eighty":-6.898786,"marketCap":1647710311},{"date":"2022-10-07","current":-13.802176,"twenty":-16.779381,"median":-10.619936,"eighty":-6.916248,"marketCap":2117267640},{"date":"2022-10-14","current":-14.91268,"twenty":-16.704843,"median":-10.68269,"eighty":-6.955732,"marketCap":2287620052},{"date":"2022-10-21","current":-15.663927,"twenty":-16.630305,"median":-10.741197,"eighty":-7.071912,"marketCap":2402862058},{"date":"2022-10-28","current":-15.698467,"twenty":-16.564048,"median":-10.820266,"eighty":-7.107086,"marketCap":2408160541},{"date":"2022-11-04","current":-14.839283,"twenty":-16.564048,"median":-11.050268,"eighty":-7.166312,"marketCap":2276360776},{"date":"2022-11-11","current":-12.241999,"twenty":-16.414972,"median":-11.147569,"eighty":-7.617391,"marketCap":2252711412},{"date":"2022-11-18","current":-12.598457,"twenty":-16.350411,"median":-11.290658,"eighty":-7.771731,"marketCap":2318305067},{"date":"2022-11-25","current":-13.952278,"twenty":-16.29605,"median":-11.35934,"eighty":-7.771731,"marketCap":2567428447},{"date":"2022-12-02","current":-14.125106,"twenty":-16.249332,"median":-11.460456,"eighty":-7.806593,"marketCap":2599231432},{"date":"2022-12-09","current":-12.836096,"twenty":-16.1662,"median":-11.775251,"eighty":-7.885736,"marketCap":2362034171},{"date":"2022-12-16","current":-12.843297,"twenty":-16.050071,"median":-11.935471,"eighty":-8.033728,"marketCap":2363359296},{"date":"2022-12-23","current":-12.803691,"twenty":-15.960795,"median":-12.029491,"eighty":-8.236016,"marketCap":2356071112},{"date":"2022-12-30","current":-13.304172,"twenty":-15.943564,"median":-12.241999,"eighty":-8.385046,"marketCap":2448167255},{"date":"2023-01-06","current":-13.318575,"twenty":-15.896517,"median":-12.362571,"eighty":-8.462395,"marketCap":2450817503},{"date":"2023-01-13","current":-13.498604,"twenty":-15.790507,"median":-12.391845,"eighty":-8.473431,"marketCap":2483945612},{"date":"2023-01-20","current":-13.275368,"twenty":-15.735846,"median":-12.443631,"eighty":-8.502082,"marketCap":2442866757},{"date":"2023-01-27","current":-14.737206,"twenty":-15.72837,"median":-12.465235,"eighty":-8.626816,"marketCap":2711867002},{"date":"2023-02-03","current":-13.192554,"twenty":-15.696004,"median":-12.546391,"eighty":-8.713372,"marketCap":2427627827},{"date":"2023-02-10","current":-12.278005,"twenty":-15.681709,"median":-12.523129,"eighty":-8.748896,"marketCap":2259337033},{"date":"2023-02-17","current":-13.368983,"twenty":-15.658746,"median":-12.575053,"eighty":-8.817175,"marketCap":2460093374},{"date":"2023-02-24","current":-12.425629,"twenty":-15.638022,"median":-12.582254,"eighty":-8.982159,"marketCap":2286502083},{"date":"2023-03-03","current":-12.321212,"twenty":-15.603334,"median":-12.537247,"eighty":-8.982567,"marketCap":2267287779},{"date":"2023-03-10","current":-11.039402,"twenty":-15.534402,"median":-12.530188,"eighty":-9.031773,"marketCap":2031415643},{"date":"2023-03-17","current":-10.186966,"twenty":-15.504179,"median":-12.49404,"eighty":-9.054954,"marketCap":2020839392},{"date":"2023-03-24","current":-9.665679,"twenty":-15.486909,"median":-12.456774,"eighty":-9.147083,"marketCap":1917428991},{"date":"2023-03-31","current":-9.867467,"twenty":-15.435099,"median":-12.43283,"eighty":-9.169128,"marketCap":1957458823},{"date":"2023-04-06","current":-9.352906,"twenty":-15.421283,"median":-12.415671,"eighty":-9.271642,"marketCap":1855382750},{"date":"2023-04-14","current":-10.284497,"twenty":-15.404013,"median":-12.363817,"eighty":-9.314874,"marketCap":2040187145},{"date":"2023-04-21","current":-10.371939,"twenty":-15.352203,"median":-12.317611,"eighty":-9.344721,"marketCap":2057533405},{"date":"2023-04-28","current":-9.540583,"twenty":-15.33867,"median":-12.281606,"eighty":-9.352541,"marketCap":1892613220},{"date":"2023-05-05","current":-9.381574,"twenty":-15.156691,"median":-12.115978,"eighty":-9.37584,"marketCap":1861069667},{"date":"2023-05-12","current":-12.985377,"twenty":-14.994752,"median":-12.108777,"eighty":-9.395229,"marketCap":1934223866},{"date":"2023-05-19","current":-12.108956,"twenty":-14.947446,"median":-12.115978,"eighty":-9.401237,"marketCap":1803677398},{"date":"2023-05-26","current":-11.860914,"twenty":-14.918725,"median":-12.116976,"eighty":-9.404582,"marketCap":1766730562},{"date":"2023-06-02","current":-11.026591,"twenty":-14.881594,"median":-12.108866,"eighty":-9.409977,"marketCap":1642454838},{"date":"2023-06-09","current":-11.838365,"twenty":-14.847918,"median":-12.041308,"eighty":-9.445302,"marketCap":1763371758},{"date":"2023-06-16","current":-11.166396,"twenty":-14.778037,"median":-12.006124,"eighty":-9.4782,"marketCap":1663279418},{"date":"2023-06-23","current":-11.175416,"twenty":-14.689959,"median":-11.960384,"eighty":-9.490139,"marketCap":1664622940},{"date":"2023-06-30","current":-9.461672,"twenty":-14.615348,"median":-11.875318,"eighty":-9.487985,"marketCap":1409353885},{"date":"2023-07-07","current":-9.276768,"twenty":-14.600384,"median":-11.818255,"eighty":-9.461672,"marketCap":1381811698},{"date":"2023-07-14","current":-10.372662,"twenty":-14.560777,"median":-11.775251,"eighty":-9.461672,"marketCap":1545049541},{"date":"2023-07-21","current":-10.106581,"twenty":-14.525026,"median":-11.523392,"eighty":-9.466753,"marketCap":1505415661},{"date":"2023-07-28","current":-10.038933,"twenty":-14.511152,"median":-11.468324,"eighty":-9.484221,"marketCap":1495339251},{"date":"2023-08-04","current":-10.169719,"twenty":-14.445559,"median":-11.399203,"eighty":-9.485831,"marketCap":1514820310},{"date":"2023-08-11","current":-19.589727,"twenty":-14.445559,"median":-11.396399,"eighty":-9.496602,"marketCap":1426386819},{"date":"2023-08-18","current":-18.701388,"twenty":-14.600384,"median":-11.401111,"eighty":-9.500016,"marketCap":1361704186},{"date":"2023-08-25","current":-20.107925,"twenty":-14.86087,"median":-11.504635,"eighty":-9.535435,"marketCap":1464118355},{"date":"2023-09-01","current":-19.950615,"twenty":-15.111286,"median":-11.536747,"eighty":-9.540583,"marketCap":1452664139},{"date":"2023-09-08","current":-19.321375,"twenty":-15.404013,"median":-11.782004,"eighty":-9.55447,"marketCap":1406847273},{"date":"2023-09-15","current":-18.146176,"twenty":-15.510224,"median":-11.838365,"eighty":-9.561304,"marketCap":1321277540},{"date":"2023-09-22","current":-16.730386,"twenty":-15.668372,"median":-11.914636,"eighty":-9.580399,"marketCap":1218189593},{"date":"2023-09-29","current":-17.119034,"twenty":-15.754066,"median":-11.982756,"eighty":-9.586985,"marketCap":1246488245},{"date":"2023-10-06","current":-16.443526,"twenty":-16.050071,"median":-12.0354,"eighty":-9.604096,"marketCap":1197302493},{"date":"2023-10-13","current":-16.29547,"twenty":-16.249332,"median":-12.108777,"eighty":-9.611049,"marketCap":1186522054},{"date":"2023-10-20","current":-15.314596,"twenty":-16.285062,"median":-12.116976,"eighty":-9.618907,"marketCap":1115101646},{"date":"2023-10-27","current":-14.759384,"twenty":-16.274178,"median":-12.163074,"eighty":-9.620949,"marketCap":1074675000},{"date":"2023-11-03","current":-16.674865,"twenty":-16.274178,"median":-12.257781,"eighty":-9.623732,"marketCap":1214146928},{"date":"2023-11-10","current":450.85384,"twenty":-16.339423,"median":-12.267893,"eighty":-9.620949,"marketCap":827767651},{"date":"2023-11-17","current":446.073172,"twenty":-16.292868,"median":-12.208173,"eighty":-9.585468,"marketCap":818990343},{"date":"2023-11-24","current":484.318522,"twenty":-16.28246,"median":-12.115978,"eighty":-9.540583,"marketCap":889208807},{"date":"2023-12-01","current":520.725154,"twenty":-16.24105,"median":-12.108777,"eighty":-9.485831,"marketCap":956051382},{"date":"2023-12-08","current":522.931616,"twenty":-16.175174,"median":-12.029491,"eighty":-9.457162,"marketCap":960102447},{"date":"2023-12-15","current":542.054291,"twenty":-16.147488,"median":-11.981987,"eighty":-9.401886,"marketCap":995211679},{"date":"2023-12-22","current":513.002535,"twenty":-16.036371,"median":-11.889723,"eighty":-9.351083,"marketCap":941872654},{"date":"2023-12-29","current":542.422035,"twenty":-16.030819,"median":-11.849639,"eighty":-9.28907,"marketCap":995886856},{"date":"2024-01-05","current":611.925604,"twenty":-16.026838,"median":-11.798146,"eighty":-9.172617,"marketCap":1123495409},{"date":"2024-01-12","current":596.480367,"twenty":-16.009487,"median":-11.66078,"eighty":-8.992408,"marketCap":1095137953},{"date":"2024-01-19","current":547.202704,"twenty":-15.944565,"median":-11.523392,"eighty":-8.742138,"marketCap":1004664164},{"date":"2024-01-26","current":565.222148,"twenty":-15.942897,"median":-11.468324,"eighty":-8.471813,"marketCap":1037747863},{"date":"2024-02-02","current":609.351398,"twenty":-15.826948,"median":-11.399203,"eighty":-7.903343,"marketCap":1118769167},{"date":"2024-02-09","current":568.531842,"twenty":-15.82354,"median":-11.35934,"eighty":-7.617391,"marketCap":1043824461},{"date":"2024-02-16","current":565.589892,"twenty":-15.749512,"median":-11.333465,"eighty":-6.955732,"marketCap":1038423041},{"date":"2024-02-23","current":25.505487,"twenty":-15.738579,"median":-11.295413,"eighty":-6.79732,"marketCap":1256680857},{"date":"2024-03-01","current":25.931954,"twenty":-15.735846,"median":-11.210528,"eighty":-6.545379,"marketCap":1277693320},{"date":"2024-03-08","current":26.097038,"twenty":-15.705943,"median":-11.186691,"eighty":-6.413487,"marketCap":1285827176},{"date":"2024-03-15","current":4.360971,"twenty":-15.688617,"median":-11.153292,"eighty":-6.087088,"marketCap":214869380},{"date":"2024-03-22","current":3.94826,"twenty":-15.668372,"median":-11.128797,"eighty":-5.859309,"marketCap":194534738},{"date":"2024-03-28","current":3.962017,"twenty":-15.648384,"median":-11.044835,"eighty":-4.906998,"marketCap":195212560},{"date":"2024-04-05","current":3.590578,"twenty":-15.617209,"median":-11.017571,"eighty":-4.329072,"marketCap":176911382},{"date":"2024-04-12","current":3.150354,"twenty":-15.591102,"median":-10.839424,"eighty":-4.211287,"marketCap":155221098},{"date":"2024-04-19","current":2.723887,"twenty":-15.55382,"median":-10.788969,"eighty":-4.079021,"marketCap":134208635},{"date":"2024-04-26","current":2.456825,"twenty":-15.516268,"median":-10.74692,"eighty":-3.715047,"marketCap":121050233},{"date":"2024-05-03","current":2.760478,"twenty":-15.493817,"median":-10.721308,"eighty":2.527963,"marketCap":136011498},{"date":"2024-05-10","current":-1.807875,"twenty":-15.455823,"median":-10.639214,"eighty":2.639017,"marketCap":128530865},{"date":"2024-05-17","current":-1.750482,"twenty":-15.424737,"median":-10.575606,"eighty":2.605891,"marketCap":124450520},{"date":"2024-05-24","current":-1.702655,"twenty":-15.407467,"median":-10.55061,"eighty":2.581476,"marketCap":121050233},{"date":"2024-05-31","current":-1.607,"twenty":-15.376381,"median":-10.462744,"eighty":2.542829,"marketCap":114249658},{"date":"2024-06-07","current":-1.683524,"twenty":-15.339392,"median":-10.375302,"eighty":2.481669,"marketCap":119690118},{"date":"2024-06-14","current":-1.607,"twenty":-15.333566,"median":-10.371939,"eighty":2.451304,"marketCap":114249658},{"date":"2024-06-21","current":-1.578303,"twenty":-15.314596,"median":-10.345603,"eighty":2.42922,"marketCap":112209485},{"date":"2024-06-28","current":-1.846137,"twenty":-15.233272,"median":-10.336583,"eighty":0.837689,"marketCap":131251095},{"date":"2024-07-05","current":-1.693089,"twenty":-15.107531,"median":-10.295995,"eighty":-1.553433,"marketCap":120370175},{"date":"2024-07-12","current":-2.180928,"twenty":-15.067132,"median":-10.277956,"eighty":-1.570651,"marketCap":155053107},{"date":"2024-07-15","current":-2.066143,"twenty":-15.041754,"median":-10.273446,"eighty":-1.572564,"marketCap":146892417},{"date":"2024-08-02","current":-1.980053,"twenty":-15.016375,"median":-10.2672,"eighty":-1.574477,"marketCap":140771900},{"date":"2024-08-09","current":-0.738827,"twenty":-14.951989,"median":-10.237413,"eighty":-1.574477,"marketCap":122548442},{"date":"2024-08-16","current":-0.886592,"twenty":-14.924769,"median":-10.186966,"eighty":-0.851292,"marketCap":147058130},{"date":"2024-08-23","current":-0.91122,"twenty":-14.881594,"median":-10.176877,"eighty":-0.87551,"marketCap":151143078},{"date":"2024-08-30","current":-0.870174,"twenty":-14.847918,"median":-10.167464,"eighty":-0.872636,"marketCap":144334832},{"date":"2024-09-06","current":-0.90301,"twenty":-14.807323,"median":-10.14717,"eighty":-0.871816,"marketCap":149781429},{"date":"2024-09-13","current":-1.022044,"twenty":-14.750513,"median":-10.111091,"eighty":-0.874278,"marketCap":169525345},{"date":"2024-09-20","current":-1.182123,"twenty":-14.689959,"median":-10.097576,"eighty":-0.875099,"marketCap":196077507},{"date":"2024-09-27","current":-1.31347,"twenty":-14.611607,"median":-10.070502,"eighty":-0.880435,"marketCap":217863897},{"date":"2024-10-04","current":-1.20675,"twenty":-14.591806,"median":-10.05255,"eighty":-0.886592,"marketCap":200162455},{"date":"2024-10-11","current":-1.420189,"twenty":-14.573388,"median":-9.984815,"eighty":-0.893159,"marketCap":235565339},{"date":"2024-10-18","current":-1.609,"twenty":-14.563346,"median":-9.930486,"eighty":-0.90301,"marketCap":266883274},{"date":"2024-10-25","current":-2.01125,"twenty":-14.546477,"median":-9.907825,"eighty":-0.904652,"marketCap":333604093},{"date":"2024-10-31","current":-2.16312,"twenty":-14.522251,"median":-9.891022,"eighty":-0.907936,"marketCap":358794606},{"date":"2024-11-08","current":-1.71606,"twenty":-14.498033,"median":-9.867467,"eighty":-0.91122,"marketCap":445259340},{"date":"2024-11-15","current":-1.317221,"twenty":-14.412048,"median":-9.847288,"eighty":-0.912041,"marketCap":341773989},{"date":"2024-11-22","current":-1.361828,"twenty":-14.258948,"median":-9.820895,"eighty":-0.917787,"marketCap":353348008},{"date":"2024-11-29","current":-1.453666,"twenty":-14.182716,"median":-9.792708,"eighty":-0.927638,"marketCap":377176872},{"date":"2024-12-06","current":-1.304101,"twenty":-14.161433,"median":-9.786381,"eighty":-0.927638,"marketCap":338369865},{"date":"2024-12-13","current":-1.15716,"twenty":-14.135908,"median":-9.753975,"eighty":-0.972788,"marketCap":300243683},{"date":"2024-12-20","current":-1.039082,"twenty":-14.125106,"median":-9.730036,"eighty":-1.022044,"marketCap":269606573},{"date":"2024-12-27","current":-1.067946,"twenty":-14.113584,"median":-9.665679,"eighty":-1.031477,"marketCap":277095644},{"date":"2025-01-03","current":-1.025963,"twenty":-14.015648,"median":-9.642275,"eighty":-1.012318,"marketCap":266202449},{"date":"2025-01-10","current":-0.989228,"twenty":-13.942196,"median":-9.632047,"eighty":-1.007595,"marketCap":256670904},{"date":"2025-01-17","current":-0.918381,"twenty":-13.90403,"median":-9.621327,"eighty":-0.945698,"marketCap":238288638},{"date":"2025-01-24","current":-0.934125,"twenty":-13.865081,"median":-9.609998,"eighty":-0.927638,"marketCap":242373586},{"date":"2025-01-31","current":-0.921005,"twenty":-13.841127,"median":-9.584963,"eighty":-0.918381,"marketCap":238969462},{"date":"2025-02-07","current":-0.98398,"twenty":-13.8128,"median":-9.549263,"eighty":-0.918381,"marketCap":255309255},{"date":"2025-02-14","current":-0.941996,"twenty":-13.770986,"median":-9.500016,"eighty":-0.918381,"marketCap":244416060},{"date":"2025-02-21","current":-0.923629,"twenty":-13.646228,"median":-9.485831,"eighty":-0.918381,"marketCap":239650287},{"date":"2025-02-28","current":-0.829167,"twenty":-13.53821,"median":-9.464213,"eighty":-0.913133,"marketCap":215140598},{"date":"2025-03-07","current":-0.814527,"twenty":-13.520208,"median":-9.457162,"eighty":-0.907115,"marketCap":245777709},{"date":"2025-03-14","current":-1.077642,"twenty":-13.509406,"median":-9.403571,"eighty":-0.905261,"marketCap":325171057},{"date":"2025-03-21","current":-1.095261,"twenty":-13.498604,"median":-9.381574,"eighty":-0.907115,"marketCap":330487205},{"date":"2025-03-28","current":-1.13637,"twenty":-13.4734,"median":-9.335179,"eighty":-0.907885,"marketCap":342891551},{"date":"2025-04-04","current":-1.030661,"twenty":-13.401388,"median":-9.276768,"eighty":-0.91122,"marketCap":310994662},{"date":"2025-04-11","current":-1.024788,"twenty":-13.390586,"median":-9.158106,"eighty":-0.91122,"marketCap":309222613},{"date":"2025-04-17","current":-1.121688,"twenty":-13.373304,"median":-9.043363,"eighty":-0.91275,"marketCap":338461427},{"date":"2025-04-25","current":-1.53865,"twenty":-13.343059,"median":-8.982159,"eighty":-0.914886,"marketCap":464276932},{"date":"2025-05-02","current":-1.509287,"twenty":-13.325056,"median":-8.72416,"eighty":-0.91567,"marketCap":455416685},{"date":"2025-05-09","current":-1.854176,"twenty":-13.322175,"median":-8.475859,"eighty":-0.917856,"marketCap":405799303},{"date":"2025-05-16","current":-1.841009,"twenty":-13.322175,"median":-8.367278,"eighty":-0.918381,"marketCap":402917713},{"date":"2025-05-23","current":-2.183143,"twenty":-13.319295,"median":-7.903343,"eighty":-0.92048,"marketCap":477796226},{"date":"2025-05-30","current":-1.995784,"twenty":-13.314254,"median":-7.771731,"eighty":-0.922579,"marketCap":436791326},{"date":"2025-06-06","current":-2.05688,"twenty":-13.307052,"median":-7.391851,"eighty":-0.923629,"marketCap":450162489},{"date":"2025-06-13","current":-2.248312,"twenty":-13.28689,"median":-7.071912,"eighty":-0.925203,"marketCap":492058800},{"date":"2025-06-20","current":-2.077245,"twenty":-13.269029,"median":-6.916248,"eighty":-0.926807,"marketCap":454619543},{"date":"2025-06-27","current":-2.647469,"twenty":-13.234175,"median":-6.748144,"eighty":-0.927638,"marketCap":579417065},{"date":"2025-07-03","current":-2.566008,"twenty":-13.195435,"median":-6.610248,"eighty":-0.928935,"marketCap":561588848},{"date":"2025-07-11","current":-3.009968,"twenty":-13.176711,"median":-6.543926,"eighty":-0.934125,"marketCap":658752632},{"date":"2025-07-18","current":-3.372468,"twenty":-13.112621,"median":-6.486852,"eighty":-0.935699,"marketCap":738088200},{"date":"2025-07-25","current":-3.380614,"twenty":-13.094618,"median":-6.275417,"eighty":-0.942521,"marketCap":739871022},{"date":"2025-08-01","current":-3.270642,"twenty":-13.033049,"median":-6.057475,"eighty":-0.94462,"marketCap":715802928}],"updateTime":1754133018028}}}